SV Health Investors is a global private equity and venture capital investment platform specialized in healthcare funds spanning all sectors and stages, including biotechnology (including dementia), healthcare growth equity, and medtech. With over 30 years of track record in the US and UK, offices in Boston and London, and a team of more than 50 investment professionals, it invests in therapeutics, healthcare services, digital health, medical products, and devices, managing approximately $4 billion in historical commitments and having backed 75 IPOs/M&As and 30 novel drugs.
